Uwe Liebchen
Impact in
-
- Antibiotic Use and Resistance
- Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
- Pharmacology 23
- Antibiotics Pharmacokinetics and Efficacy 23
-
- Antimicrobial Resistance in Staphylococcus 4
- Antifungal resistance and susceptibility 3
- Co-authors
- Christina Scharf (36 shared papers)Michael Paal (29 shared papers)Michael Zöller (32 shared papers)Ines Schroeder (14 shared papers)Michael Irlbeck (15 shared papers)Frieder Kees (5 shared papers)Alexander Kratzer (5 shared papers)Martin G. Kees (5 shared papers)
- Journals
- Antibiotics (5 papers)Antimicrobial Agents and Chemotherapy (4 papers)Annals of Intensive Care (3 papers)Journal of Critical Care (3 papers)Scientific Reports (3 papers)
- Partner nations
- GermanyUnited StatesCanada
In The Last Decade
Uwe Liebchen
47 papers receiving 802 citations
Peers
Comparison fields: 5 of 80
- Applied Microbiology and Biotechnology 52
- Pharmacology 372
- Molecular Medicine 79
- Analytical Chemistry 70
- Critical Care and Intensive Care Medicine 28
Countries citing papers authored by Uwe Liebchen
This map shows the geographic impact of Uwe Liebchen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uwe Liebchen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uwe Liebchen more than expected).
Fields of papers citing papers by Uwe Liebchen
This network shows the impact of papers produced by Uwe Liebchen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uwe Liebchen. The network helps show where Uwe Liebchen may publish in the future.
Co-authors
The 25 scholars most cited alongside Uwe Liebchen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 81 | |
| 2 | 2021 | 76 | |
| 3 | 2014 | 61 | |
| 4 | 2021 | 59 | |
| 5 | 2020 | 49 | |
| 6 | 2020 | 43 | |
| 7 | 2021 | 42 | |
| 8 | 2021 | 38 | |
| 9 | 2020 | 36 | |
| 10 | 2017 | 31 | |
| 11 | 2014 | 26 | |
| 12 | 2022 | 25 | |
| 13 | 2016 | 24 | |
| 14 | 2023 | 23 | |
| 15 | 2019 | 16 | |
| 16 | 2019 | 14 | |
| 17 | 2023 | 13 | |
| 18 | 2023 | 12 | |
| 19 | 2023 | 12 | |
| 20 | 2023 | 10 |
About Uwe Liebchen
Uwe Liebchen is a scholar working on Pharmacology, Infectious Diseases, Epidemiology, Nephrology and Pulmonary and Respiratory Medicine, having authored 52 papers that have together received 814 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (23 papers), Pneumonia and Respiratory Infections (6 papers), Antibiotic Resistance in Bacteria (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers), Antifungal resistance and susceptibility (3 papers), Electrolyte and hormonal disorders (3 papers), Epilepsy research and treatment (3 papers) and Acute Kidney Injury Research (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (52 citations), Pharmacology (372 citations), Molecular Medicine (79 citations), Analytical Chemistry (70 citations) and Critical Care and Intensive Care Medicine (28 citations). Uwe Liebchen has collaborated with scholars based in Germany, United States and Canada. Frequent co-authors include Christina Scharf, Michael Paal, Michael Zöller, Ines Schroeder, Michael Irlbeck, Frieder Kees, Alexander Kratzer, Martin G. Kees, Michael Vogeser and Bernd Salzberger. Their work appears in journals such as Antibiotics, Antimicrobial Agents and Chemotherapy, Annals of Intensive Care, Journal of Critical Care and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.